Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study criteria-Reference-Cited by-同舟云学术

Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study criteria

Published:2019-09 Issue:5 Volume:57 Page:466-471
ISSN:2212-5345
Container-title:Respiratory Investigation
language:en
Short-container-title:Respiratory Investigation

Author:

Sakaguchi Tadashi,Ito Kentaro,Furuhashi Kazuki,Nakamura Yuki,Suzuki Yuta,Nishii Yoichi,Taguchi Osamu,Hataji Osamu

Funder

Novartis

GlaxoSmithKline

Daiichi Sankyo

Bayer

Kyorin

Boehringer Ingelheim

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference8 articles.

1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

2. Therapeutic management options for stage III non-small cell lung cancer;Yoon;World J Clin Oncol,2017

3. Identification and characterization of MEDI4736, an antagonistic anti-PD-L1 monoclonal antibody;Stewart;Cancer Immunol Res,2015

4. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;N Engl J Med,2017

5. Overall survival with durvalumab after chemoradiotherapy in stage Ⅲ NSCLC;Antonia;N Engl J Med,2018

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pneumonitis Risk After Chemoradiotherapy With and Without Immunotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis;International Journal of Radiation Oncology*Biology*Physics;2024-07

2. Chemotherapy-free radiotherapy combined with immune checkpoint inhibitors: a new regimen for locally advanced non-small cell lung cancer?;Cancer Biology & Medicine;2024-02-05

3. The Best Supportive Care in Stage III Non-Small-Cell Lung Cancer;Current Oncology;2023-12-29

4. Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis;eClinicalMedicine;2023-10

5. Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer;Clinical and Translational Radiation Oncology;2023-07